| Company Name: |
Energy Chemical |
| Tel: |
400-0056266 |
| Email: |
marketing1@energy-chemical.com |
4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide manufacturers
- DS1
-
- $1980.00
-
2026-05-11
- CAS:372497-52-4
- Purity:
- Supply Ability: 10g
|
| | 4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide Basic information |
| Product Name: | 4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide | | Synonyms: | 4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide;4-chloro-N-[6,8-dibromo-2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide;Benzamide, 4-chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridin-3-yl]-;DS1, CAS 372497-52-4 | | CAS: | 372497-52-4 | | MF: | C18H10Br2ClN3OS | | MW: | 511.62 | | EINECS: | | | Product Categories: | | | Mol File: | 372497-52-4.mol | ![4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide Structure](CAS/20180702/GIF/372497-52-4.gif) |
| | 4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide Chemical Properties |
| storage temp. | 2-8°C | | solubility | DMSO: >10mg/mL | | form | powder | | color | off-white to tan | | InChI | 1S/C18H10Br2ClN3OS/c19-11-8-13(20)16-22-15(14-2-1-7-26-14)17(24(16)9-11)23-18(25)10-3-5-12(21)6-4-10/h1-9H,(H,23,25) | | InChIKey | MEWSBNIVOLYKGU-UHFFFAOYSA-N | | SMILES | Clc1ccc(cc1)C(=O)Nc2c(nc3c(Br)cc(Br)cn23)-c4cccs4 |
| Hazard Codes | Xn | | Risk Statements | 22 | | WGK Germany | 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral |
| | 4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide Usage And Synthesis |
| Uses | DS1 is a GABAA receptor agonist which can stimulate gonadotropin subunit gene expression in mouse. | | Biological Activity | δ-GABAA receptors are emerging as an important pharmacological target. DS1 potently (low nM) enhances GABA-evoked currents mediated by α4β3δ receptors. It had little effect on GABA responses mediated by α4β3γ2 receptors. at similar concentrations DS1 directly activates this receptor and is the most potent known agonist of α4β3δ receptors. This compound has an opportunity to be become an agonist golden stardard for δ-GABAA receptors.', 'DS1 potently (low nM) enhances GABA-evoked currents mediated by GABAA α4β3δ receptor subtype. at similar concentrations, it acts as a direct agonist at this receptor and is the most potent agonist known. It has little effect on GABA responses mediated by α4β3γ2 receptors. |
| | 4-Chloro-N-[6,8-dibromo-2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl]benzamide Preparation Products And Raw materials |
|